To report a violation click
here:
https://secure.ethicspoint.com/domain/en/report_custom.asp?clientid=8630
Or call 800-530-1851
Summary
The Ranbaxy Inc. Compliance Program (the "Program")
covers Ranbaxy Inc. and all of its U.S. subsidiaries (the "Company").
The Program was created to assist the board of directors in
overseeing and responding to compliance issues affecting the
Company and is one of the mechanisms utilized by the Company
to receive information concerning compliance with laws and regulations
governing the Company's business.
As part of the Program, the Company has developed
and continues to review policies and procedures through which
the Company complies with the various federal and state laws
affecting the Company, including the framework necessary to
ensure an effective compliance program to prevent and detect
violations of the law. To that end, the Company has established
a Compliance Committee which reports to the Board of Directors
of the Company, and will function to support: (i) compliance
by the Company with legal and regulatory requirements; (ii)
adherence by the Company with the highest ethical standards
in all business activities, including, without limitation, the
Company's Code of Conduct; (iii) assessment of the Company's
compliance risks; (iv) development of uniform disciplinary standards
for compliance failures; and (v) each of the Company's departments
in preparing a compliance risk assessment.
The composition of the Compliance Committee includes at least
one representative from the various functional areas, including,
without limitation, Legal, Finance & Accounting, Human Resources,
Sales & Marketing, Regulatory Affairs and Corporate Governance.
The Compliance Committee is endeavored to meet on a periodic
basis. The Compliance Committee is charged with communicating
to the board of directors of the Company regarding compliance
and adherence with laws, regulations and the Company's own policies,
and will oversee and provide guidance on the implementation
of the Program, including proactive training of employees and
communication programs. The training programs will include education
designed to ensure employees have an awareness of legal requirements
that are relevant to their work at a level of detail appropriate
to their job functions.
Employees of the Company are encouraged to
address questions or concerns with management. The employee
may also direct questions or concerns regarding the Company's
standards of conduct to ethics advisors or to the Company's
Ethics Hotline. Retaliation against employees who raise concerns
to any Company source will not be tolerated, and retaliation
against any employee for proper use of the reporting mechanisms
is cause for appropriate corrective action.
Declaration
To the best of its knowledge, information and belief, Ranbaxy
Inc. and its U.S. subsidiaries (the "Company") is
in compliance, as of July 1, 2006 and in all material respects,
with its Compliance Program and its good faith understanding
of the requirements of California Health and Safety Code Section
119400 thru 119402. A copy of this document can be obtained
by contacting the Company at (888) RANBAXY (726-2299).
|
